ADMA
Time to buy ADMA?$7.93
+$0.10 (1.26%)
2 Days. Real Options Skills.
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatTrader's Perspective
ADMA faded from about $15.57 in early March to $7.98 by May 30, 2026 after a March short report pressured the stock, even as management answered back, won an FDA label expansion for ASCENIV, and posted profitable first quarter results.
The stock has the potential to go down if it loses the $7.75 area and cannot reclaim it fast. That could open a retrace toward $7.21, and any renewed pressure around the short-seller claims, weaker immune globulin pricing, or another guidance reset would accelerate the downside.
If ADMA holds the $7.75 to $8.00 area and starts reclaiming volume, a bounce toward $9.50 to $10.50 is on the table. Resistance near $8.50 is the first hurdle, then the stock has room if buyback support and ASCENIV growth stay in focus.
Analyst Ratings
ADMA Biologics Inc Earnings
We don't currently have information about ADMA Biologics Inc's earnings.